RepliCel Life Sciences Inc.

TSXV:RP Stock Report

Market Cap: CA$191.2k

RepliCel Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies9,344,58414.4%
General Public23,063,90535.5%
Individual Insiders32,593,07150.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 12 shareholders own 64.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.8%
Andrew Schutte
17,401,616CA$51.2k0%no data
15.4%
Jamie MacKay
10,034,537CA$29.5k0%no data
8.24%
YOFOTO (China) Health Industry Co. Ltd.
5,357,900CA$15.8k0%no data
6.13%
Mainpointe Pharmaceuticals, LLC
3,986,684CA$11.7k0%no data
2.04%
Kevin McElwee
1,329,245CA$3.9k0%no data
1.84%
Peter Lowry
1,193,426CA$3.5k0%no data
1.35%
David Hall
875,632CA$2.6k0%no data
0.96%
Peter Lewis
626,920CA$1.8k0%no data
0.75%
Rolf Hoffmann
489,572CA$1.4k0%no data
0.49%
Ben Austring
320,500CA$942.80%no data
0.48%
Gary Boddington
314,815CA$926.10%no data
0.01%
R. Buckler
6,808CA$20.00%no data